COVID-19 treatments such as Pfizer’s Paxlovid or Merck’s Molnupiravir remain undersupplied globally. Prashant Yadav (CGD, INSEAD) joins to describe how companies so far have shared their intellectual property through the Medicines Patent Pool and what else is needed to unlock global production bottlenecks (42:04).
- Javier Guzman, Julia Kaufman, Prashant Yadav. 2022. Policy Actions for the US Government to Accelerate Access to Oral Antivirals for COVID-19 in Low- and Middle-Income Countries. CGD Note, April.
- Monica de Bolle. 2022. We need an Operation Warp Speed for COVID-19 treatments. PIIE Realtime Economic Issues Watch, June 13.
- Chad P. Bown. 2022. The US was quick to produce COVID-19 vaccines. Then it fell behind. PIIE Realtime Economic Issues Watch, June 21.
- Chad P. Bown. Forthcoming. COVID-19 vaccine supply chains and the Defense Production Act. Oxford Review of Economic Policy.